FDAnews Device Daily Bulletin

Singapore Hub Forms International Alliance With Industry

Dec. 22, 2015

Singapore's Diagnostics Development Hub is teaming up with the North Shore-Long Island Jewish Health System’s Feinstein Institute for Medical Research and Ireland’s i360medical to develop medical device and diagnostic technologies that will target surgical procedures, intraoperative diagnostics and diabetic management.

The organizations will work together to identify and evaluate pipeline projects, with the aim of developing technologies with high potential for clinical and commercialization impact.

Under the agreement, the Feinstein Institute will have access to the Singapore’s DxD Hub’s Asian and i360's European clinical networks. In return, the DxD Hub and i360 can access the institute’s clinical network of opinion leaders.

Financial terms of the agreement were not disclosed. — Michael Cipriano